207 related articles for article (PubMed ID: 22998478)
41. Scrapie-induced defects in learning and memory of transgenic mice expressing anchorless prion protein are associated with alterations in the gamma aminobutyric acid-ergic pathway.
Trifilo MJ; Sanchez-Alavez M; Solforosi L; Bernard-Trifilo J; Kunz S; McGavern D; Oldstone MB
J Virol; 2008 Oct; 82(20):9890-9. PubMed ID: 18667494
[TBL] [Abstract][Full Text] [Related]
42. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
43. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
Prusiner SB
Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
[TBL] [Abstract][Full Text] [Related]
44. Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases.
Reiniger L; Mirabile I; Lukic A; Wadsworth JD; Linehan JM; Groves M; Lowe J; Druyeh R; Rudge P; Collinge J; Mead S; Brandner S
Acta Neuropathol Commun; 2013 May; 1(1):8. PubMed ID: 24252267
[TBL] [Abstract][Full Text] [Related]
45. Genetic and infectious prion diseases.
Prusiner SB
Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
[TBL] [Abstract][Full Text] [Related]
46. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
[TBL] [Abstract][Full Text] [Related]
47. Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels.
Tribouillard-Tanvier D; Striebel JF; Peterson KE; Chesebro B
J Virol; 2009 Nov; 83(21):11244-53. PubMed ID: 19710140
[TBL] [Abstract][Full Text] [Related]
48. Region-specific protein misfolding cyclic amplification reproduces brain tropism of prion strains.
Privat N; Levavasseur E; Yildirim S; Hannaoui S; Brandel JP; Laplanche JL; Béringue V; Seilhean D; Haïk S
J Biol Chem; 2017 Oct; 292(40):16688-16696. PubMed ID: 28821618
[TBL] [Abstract][Full Text] [Related]
49. How well does the CSF inform upon pathology in the brain in Creutzfeldt-Jakob and Alzheimer's diseases?
Weller RO
J Pathol; 2001 May; 194(1):1-3. PubMed ID: 11329133
[TBL] [Abstract][Full Text] [Related]
50. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
51. Strain specific resistance to murine scrapie associated with a naturally occurring human prion protein polymorphism at residue 171.
Striebel JF; Race B; Meade-White KD; LaCasse R; Chesebro B
PLoS Pathog; 2011 Sep; 7(9):e1002275. PubMed ID: 21980292
[TBL] [Abstract][Full Text] [Related]
52. Molecular cross talk between misfolded proteins in animal models of Alzheimer's and prion diseases.
Morales R; Estrada LD; Diaz-Espinoza R; Morales-Scheihing D; Jara MC; Castilla J; Soto C
J Neurosci; 2010 Mar; 30(13):4528-35. PubMed ID: 20357103
[TBL] [Abstract][Full Text] [Related]
53. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
[TBL] [Abstract][Full Text] [Related]
54. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models.
Arbel-Ornath M; Hudry E; Eikermann-Haerter K; Hou S; Gregory JL; Zhao L; Betensky RA; Frosch MP; Greenberg SM; Bacskai BJ
Acta Neuropathol; 2013 Sep; 126(3):353-64. PubMed ID: 23818064
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of quinacrine treatment for prion diseases.
Barret A; Tagliavini F; Forloni G; Bate C; Salmona M; Colombo L; De Luigi A; Limido L; Suardi S; Rossi G; Auvré F; Adjou KT; Salès N; Williams A; Lasmézas C; Deslys JP
J Virol; 2003 Aug; 77(15):8462-9. PubMed ID: 12857915
[TBL] [Abstract][Full Text] [Related]
56. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein.
Stewart RS; Piccardo P; Ghetti B; Harris DA
J Neurosci; 2005 Mar; 25(13):3469-77. PubMed ID: 15800202
[TBL] [Abstract][Full Text] [Related]
57. Re-transmissibility of mouse-adapted ME7 scrapie strain to ovine PrP transgenic mice.
Babalola JA; Kim JM; Lee YJ; Park JH; Choi HS; Choi YG; Choi EK; Kim YS
J Vet Sci; 2019 Mar; 20(2):e8. PubMed ID: 30944531
[TBL] [Abstract][Full Text] [Related]
58. Remarkable increases of α1-antichymotrypsin in brain tissues of rodents during prion infection.
Chen C; Xu XF; Zhang RQ; Ma Y; Lv Y; Li JL; Shi Q; Xiao K; Sun J; Yang XD; Shi Q; Dong XP
Prion; 2017 Sep; 11(5):338-351. PubMed ID: 28956708
[TBL] [Abstract][Full Text] [Related]
59. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
60. Isolation of novel synthetic prion strains by amplification in transgenic mice coexpressing wild-type and anchorless prion proteins.
Raymond GJ; Race B; Hollister JR; Offerdahl DK; Moore RA; Kodali R; Raymond LD; Hughson AG; Rosenke R; Long D; Dorward DW; Baron GS
J Virol; 2012 Nov; 86(21):11763-78. PubMed ID: 22915801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]